BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11598617)

  • 61. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    David M; Sempé M; Blanc M; Nicolino M; Forest MG; Morel Y
    Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
    [No Abstract]   [Full Text] [Related]  

  • 62. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.
    Rappaport R; Bouthreuil E; Marti-Henneberg C; Basmaciogullari A
    Acta Paediatr Scand; 1973 Sep; 62(5):513-9. PubMed ID: 4754146
    [No Abstract]   [Full Text] [Related]  

  • 64. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.
    Punthakee Z; Legault L; Polychronakos C
    J Pediatr; 2003 Sep; 143(3):402-5. PubMed ID: 14517528
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Congenital adrenal hyperplasia: molecular genetics and alternative approaches to treatment.
    Laue L; Rennert OM
    Adv Pediatr; 1995; 42():113-43. PubMed ID: 8540426
    [No Abstract]   [Full Text] [Related]  

  • 67. LHRH analog treatment of central precocious puberty complicating congenital adrenal hyperplasia.
    Pescovitz OH; Cassorla F; Comite F; Loriaux DL; Cutler GB
    Ann N Y Acad Sci; 1985; 458():174-81. PubMed ID: 3911847
    [No Abstract]   [Full Text] [Related]  

  • 68. [Congenital adrenal cortex hyperplasia (AGS). Clinical courses following diagnostic and therapeutic omissions].
    Stolecke H; Zimmermann E
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):409-10. PubMed ID: 4751477
    [No Abstract]   [Full Text] [Related]  

  • 69. Growth and development in children with classic congenital adrenal hyperplasia.
    Bonfig W
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):39-42. PubMed ID: 27898585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Precocious puberty in a girl with congenital adrenal hyperplasia following the initiation of hydrocortisone replacement therapy (author's transl)].
    Dumić M; Radica A; Tajić M; Crnojević-Ivanusić R
    Lijec Vjesn; 1981 Jun; 103(6):242-4. PubMed ID: 7321748
    [No Abstract]   [Full Text] [Related]  

  • 71. Congenital adrenal hyperplasia: adolescence and transition.
    Conway GS
    Horm Res; 2007; 68 Suppl 5():155-7. PubMed ID: 18174736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty.
    Güven A; Nurcan Cebeci A; Hancili S
    Hormones (Athens); 2015; 14(2):265-71. PubMed ID: 25553759
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Female pseudohermaphroditism].
    Terao Y; Takeuchi H; Kinoshita K
    Nihon Rinsho; 2006 Jun; Suppl 2():550-3. PubMed ID: 16817463
    [No Abstract]   [Full Text] [Related]  

  • 74. Congenital adrenal hyperplasia: Results of medical therapy on appearance of external genitalia.
    Kulshreshtha B; Khadgawat R; Eunice M; Ammini AC
    J Pediatr Urol; 2010 Dec; 6(6):555-9. PubMed ID: 20117057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monitoring treatment in congenital adrenal hyperplasia.
    Appan S; Hindmarsh PC; Brook CG
    Arch Dis Child; 1989 Sep; 64(9):1235-9. PubMed ID: 2640553
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC; Hughes IA
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?
    Mooij CF; Kroese JM; Claahsen-van der Grinten HL; Tack CJ; Hermus AR
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):137-46. PubMed ID: 19719762
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
    Lisá L
    Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone Mineral Content and Density in Indian Children with Congenital Adrenal Hyperplasia.
    Ganesh R; Suresh N; Janakiraman L
    Indian Pediatr; 2018 Oct; 55(10):880-882. PubMed ID: 29941696
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA; Krone N
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.